$EXAS
EXACT SCIENCES CORP Stock $exas

$exas Overview Financials Valuation SEC Filings Company Website

2012 Q2 Form 10-Q Financial Statement

#000110465912051460 Filed on July 26, 2012

Income Statement

Concept	2012 Q2	2011 Q2
Revenue	$1.036M	$1.042M
YoY Change	-0.58%	-19.85%
Cost Of Revenue	$0.00	$6.000K
YoY Change	-100.0%
Gross Profit	$1.036M	$1.036M
YoY Change	0.0%	-20.31%
Gross Profit Margin	100.0%	99.42%
Selling, General & Admin	$3.724M	$2.481M
YoY Change	50.1%	45.94%
% of Gross Profit	359.46%	239.48%
Research & Development	$12.20M	$5.197M
YoY Change	134.79%	147.48%
% of Gross Profit	1177.8%	501.64%
Depreciation & Amortization	$200.0K	$0.00
YoY Change		-100.0%
% of Gross Profit	19.31%	0.0%
Operating Expenses	$15.93M	$7.678M
YoY Change	107.42%	102.05%
Operating Profit	-$14.89M	-$6.642M
YoY Change	124.18%	165.68%
Interest Expense	$5.000K	$5.000K
YoY Change	0.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$14.80M	-$6.600M
YoY Change	124.24%	164.0%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$14.80M	-$6.600M
YoY Change	124.24%	164.0%
Net Earnings / Revenue	-1428.57%	-633.4%
Basic Earnings Per Share
Diluted Earnings Per Share	-$259.6K	-$126.9K
COMMON SHARES
Basic Shares Outstanding	57.14M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2012 Q2	2011 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$70.90M	$83.50M
YoY Change	-15.09%	123.86%
Cash & Equivalents	$6.026M	$38.26M
Short-Term Investments	$64.80M	$45.20M
Other Short-Term Assets	$2.300M	$600.0K
YoY Change	283.33%	-40.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$73.21M	$84.10M
YoY Change	-12.95%	119.01%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.870M	$1.400M
YoY Change	105.0%	100.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$2.870M	$1.400M
YoY Change	105.0%	100.0%
TOTAL ASSETS
Total Short-Term Assets	$73.21M	$84.10M
Total Long-Term Assets	$2.870M	$1.400M
Total Assets	$76.08M	$85.50M
YoY Change	-11.02%	118.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$800.0K	$1.100M
YoY Change	-27.27%	83.33%
Accrued Expenses	$3.700M	$1.800M
YoY Change	105.56%	20.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$8.639M	$7.100M
YoY Change	21.68%	-6.58%
LONG-TERM LIABILITIES
Long-Term Debt	$1.000M	$1.000M
YoY Change	0.0%	0.0%
Other Long-Term Liabilities	$2.400M	$6.500M
YoY Change	-63.08%	-35.0%
Total Long-Term Liabilities	$3.400M	$7.500M
YoY Change	-54.67%	-31.82%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.639M	$7.100M
Total Long-Term Liabilities	$3.400M	$7.500M
Total Liabilities	$12.10M	$14.60M
YoY Change	-17.12%	-21.51%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$64.02M	$70.90M
YoY Change
Total Liabilities & Shareholders Equity	$76.08M	$85.50M
YoY Change	-11.02%	118.67%

Cashflow Statement

Concept	2012 Q2	2011 Q2
OPERATING ACTIVITIES
Net Income	-$14.80M	-$6.600M
YoY Change	124.24%	164.0%
Depreciation, Depletion And Amortization	$200.0K	$0.00
YoY Change		-100.0%
Cash From Operating Activities	-$12.30M	-$5.900M
YoY Change	108.47%	126.92%
INVESTING ACTIVITIES
Capital Expenditures	-$500.0K	-$500.0K
YoY Change	0.0%	150.0%
Acquisitions
YoY Change
Other Investing Activities	$6.300M	-$27.60M
YoY Change	-122.83%	210.11%
Cash From Investing Activities	$5.800M	-$28.10M
YoY Change	-120.64%	208.79%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	300.0K	200.0K
YoY Change	50.0%	-98.88%
NET CHANGE
Cash From Operating Activities	-12.30M	-5.900M
Cash From Investing Activities	5.800M	-28.10M
Cash From Financing Activities	300.0K	200.0K
Net Change In Cash	-6.200M	-33.80M
YoY Change	-81.66%	-654.1%
FREE CASH FLOW
Cash From Operating Activities	-$12.30M	-$5.900M
Capital Expenditures	-$500.0K	-$500.0K
Free Cash Flow	-$11.80M	-$5.400M
YoY Change	118.52%	125.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Revenues Revenues	2082000	USD
	us-gaap	Licenses Revenue LicensesRevenue	2072000	USD
	us-gaap	Royalty Revenue RoyaltyRevenue	10000	USD
CY2011Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1034000	USD
CY2011Q4	us-gaap	Assets Current AssetsCurrent	94395000	USD
CY2011Q4	exas	Laboratory Equipment Gross LaboratoryEquipmentGross	2314000	USD
CY2011Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2011Q4	exas	Office And Computer Equipment Gross OfficeAndComputerEquipmentGross	729000	USD
CY2011Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	288000	USD
CY2011Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	23000	USD
CY2011Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3354000	USD
CY2011Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	796000	USD
CY2011Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2558000	USD
CY2011Q4	us-gaap	Assets Assets	96953000	USD
CY2011Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	765000	USD
CY2011Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3069000	USD
CY2011Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4143000	USD
CY2011Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7977000	USD
CY2011Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1000000	USD
CY2011Q4	exas	Interest Payable Noncurrent InterestPayableNoncurrent	42000	USD
CY2011Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	4439000	USD
CY2011Q4	us-gaap	Common Stock Value CommonStockValue	566000	USD
CY2011Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	304767000	USD
CY2011Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-14000	USD
CY2011Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-221824000	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	83495000	USD
CY2011Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	96953000	USD
CY2011Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2011Q4	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2012Q2	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2012Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	76082000	USD
CY2012Q2	us-gaap	Stockholders Equity StockholdersEquity	64024000	USD
CY2012Q2	us-gaap	Liabilities Current LiabilitiesCurrent	8639000	USD
CY2012Q2	us-gaap	Assets Assets	76082000	USD
CY2012Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2870000	USD
CY2012Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4083000	USD
CY2012Q2	us-gaap	Assets Current AssetsCurrent	73212000	USD
CY2012Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	64839000	USD
CY2012Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6026000	USD
CY2011Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	56624763	shares
CY2012Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	57339933	shares
CY2011Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	56624763	shares
CY2012Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	57339933	shares
CY2011Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2012Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2011Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2012Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2011Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2012Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2012Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2011Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2012Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2011Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2012Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10998000	USD
	us-gaap	Interest Expense InterestExpense	10000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	56000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-11044000	USD
	us-gaap	Gross Profit GrossProfit	2070000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	12000	USD
CY2011Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6625000	USD
CY2011Q2	us-gaap	Interest Expense InterestExpense	5000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-25592000	USD
CY2011Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	22000	USD
CY2011Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-6642000	USD
CY2012Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-14890000	USD
	us-gaap	Operating Expenses OperatingExpenses	27664000	USD
CY2011Q2	us-gaap	Operating Expenses OperatingExpenses	7678000	USD
CY2011Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	651000	USD
CY2012Q2	us-gaap	Operating Expenses OperatingExpenses	15926000	USD
	us-gaap	Gross Profit GrossProfit	2072000	USD
	us-gaap	Revenues Revenues	2072000	USD
CY2011Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1830000	USD
CY2011Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5197000	USD
CY2011Q2	us-gaap	Gross Profit GrossProfit	1036000	USD
CY2012Q2	us-gaap	Gross Profit GrossProfit	1036000	USD
CY2011Q2	us-gaap	Cost Of Revenue CostOfRevenue	6000	USD
CY2011Q2	us-gaap	Revenues Revenues	1042000	USD
CY2011Q2	us-gaap	Licenses Revenue LicensesRevenue	1036000	USD
CY2011Q2	us-gaap	Royalty Revenue RoyaltyRevenue	6000	USD
CY2012Q2	us-gaap	Revenues Revenues	1036000	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.21
CY2011Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.13
	us-gaap	Deferred Compensation Arrangement With Individual Employer Contribution DeferredCompensationArrangementWithIndividualEmployerContribution	169000	USD
	us-gaap	Available For Sale Securities Change In Net Unrealized Holding Gain Loss AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLoss	-13000	USD
CY2011Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	38264000	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	78752000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-40488000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	225000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	225000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-29264000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	711000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	12626000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	41179000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-11449000	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	10000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	167000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	58000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	365000	USD
	us-gaap	Deferred Revenue Revenue Recognized DeferredRevenueRevenueRecognized	-2072000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1552000	USD
	us-gaap	Depreciation Depreciation	145000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-29755000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	1864000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-7921000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-23698000	USD
	us-gaap	Deferred Compensation Arrangement With Individual Shares Issued DeferredCompensationArrangementWithIndividualSharesIssued	27872	shares
	us-gaap	Deferred Compensation Arrangement With Individual Shares Issued DeferredCompensationArrangementWithIndividualSharesIssued	32872	shares

Files In Submission

Name	View Source	Status
0001104659-12-051460-index-headers.html	Edgar Link	pending
0001104659-12-051460-index.html	Edgar Link	pending
0001104659-12-051460.txt	Edgar Link	pending
0001104659-12-051460-xbrl.zip	Edgar Link	pending
a12-13684_110q.htm	Edgar Link	pending
a12-13684_1ex10d1.htm	Edgar Link	pending
a12-13684_1ex31d1.htm	Edgar Link	pending
a12-13684_1ex31d2.htm	Edgar Link	pending
a12-13684_1ex32d1.htm	Edgar Link	pending
exas-20120630.xml	Edgar Link	completed
exas-20120630.xsd	Edgar Link	pending
exas-20120630_cal.xml	Edgar Link	unprocessable
exas-20120630_def.xml	Edgar Link	unprocessable
exas-20120630_lab.xml	Edgar Link	unprocessable
exas-20120630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EXAS
EXACT SCIENCES CORP Stock $exas

2012 Q2 Form 10-Q Financial Statement

#000110465912051460 Filed on July 26, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EXAS EXACT SCIENCES CORP Stock $exas

2012 Q2 Form 10-Q Financial Statement

#000110465912051460 Filed on July 26, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EXAS
EXACT SCIENCES CORP Stock $exas